Engineering hydrophobicity and manufacturability for optimized biparatopic antibody–drug conjugates targeting c-MET
Optimal combinations of paratopes assembled into a biparatopic antibody have the capacity to mediate high-grade target cross-linking on cell membranes, leading to degradation of the target, as well as antibody and payload delivery in the case of an antibody-drug conjugate (ADC). In the work presente...
Saved in:
| Main Authors: | Andreas Evers, Simon Krah, Deniz Demir, Ramona Gaa, Desislava Elter, Christian Schroeter, Stefan Zielonka, Nicolas Rasche, Julia Dotterweich, Christine Knuehl, Achim Doerner |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2302386 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leveraging HER2-targeted biparatopic antibodies in solid tumors
by: Xinlin Liu, et al.
Published: (2025-04-01) -
Biparatopic antibodies: therapeutic applications and prospects
by: David L. Niquille, et al.
Published: (2024-12-01) -
Building a potent TREM2 agonistic, biparatopic, common light chain antibody
by: Ana da Silva Almeida, et al.
Published: (2025-12-01) -
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidity
by: Jeremy Loyau, et al.
Published: (2025-12-01) -
Treatment of c-MET Antibody-Drug Conjugate Asymptomatic Pneumonitis with a Novel Steroid Regimen in Non–Small Cell Lung Cancer: A Case Report
by: Daniel A. Fox, et al.
Published: (2025-02-01)